Geode Capital Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.62M Buy
112,138
+99,016
+755% +$2.31M ﹤0.01% 3050
2025
Q1
$200K Buy
13,122
+561
+4% +$8.54K ﹤0.01% 3850
2024
Q4
$231K Sell
12,561
-1
-0% -$18 ﹤0.01% 3861
2024
Q3
$139K Sell
12,562
-568
-4% -$6.3K ﹤0.01% 4012
2024
Q2
$122K Sell
13,130
-15,248
-54% -$142K ﹤0.01% 4081
2024
Q1
$930K Buy
28,378
+351
+1% +$11.5K ﹤0.01% 3390
2023
Q4
$750K Buy
28,027
+1,003
+4% +$26.8K ﹤0.01% 3459
2023
Q3
$1.63M Buy
27,024
+1,071
+4% +$64.8K ﹤0.01% 3142
2023
Q2
$2.64M Buy
25,953
+1,166
+5% +$119K ﹤0.01% 3025
2023
Q1
$4.38M Buy
24,787
+972
+4% +$172K ﹤0.01% 2691
2022
Q4
$9.21M Buy
23,815
+1,032
+5% +$399K ﹤0.01% 2320
2022
Q3
$7.68M Buy
22,783
+54
+0.2% +$18.2K ﹤0.01% 2431
2022
Q2
$7.47M Buy
22,729
+378
+2% +$124K ﹤0.01% 2454
2022
Q1
$9.78M Sell
22,351
-1,011
-4% -$442K ﹤0.01% 2358
2021
Q4
$10.2M Buy
23,362
+108
+0.5% +$47.4K ﹤0.01% 2431
2021
Q3
$12.9M Buy
23,254
+1,242
+6% +$691K ﹤0.01% 2273
2021
Q2
$11.3M Buy
22,012
+1,958
+10% +$1.01M ﹤0.01% 2375
2021
Q1
$15.7M Buy
20,054
+1,279
+7% +$1,000K ﹤0.01% 2032
2020
Q4
$10.2M Buy
18,775
+860
+5% +$468K ﹤0.01% 2171
2020
Q3
$8.21M Buy
17,915
+366
+2% +$168K ﹤0.01% 2074
2020
Q2
$10.8M Buy
17,549
+649
+4% +$400K ﹤0.01% 1891
2020
Q1
$8.04M Buy
16,900
+1,887
+13% +$897K ﹤0.01% 1871
2019
Q4
$8.71M Buy
15,013
+422
+3% +$245K ﹤0.01% 2109
2019
Q3
$9.6M Buy
14,591
+2,192
+18% +$1.44M ﹤0.01% 1968
2019
Q2
$9.6M Buy
12,399
+1,345
+12% +$1.04M ﹤0.01% 1988
2019
Q1
$7.81M Buy
11,054
+823
+8% +$581K ﹤0.01% 2058
2018
Q4
$4.79M Buy
10,231
+574
+6% +$269K ﹤0.01% 2250
2018
Q3
$8.33M Buy
9,657
+2,714
+39% +$2.34M ﹤0.01% 2050
2018
Q2
$4.79M Buy
6,943
+580
+9% +$400K ﹤0.01% 2351
2018
Q1
$2.84M Buy
6,363
+91
+1% +$40.5K ﹤0.01% 2575
2017
Q4
$2.76M Buy
6,272
+93
+2% +$41K ﹤0.01% 2575
2017
Q3
$3.05M Buy
6,179
+102
+2% +$50.3K ﹤0.01% 2496
2017
Q2
$3.37M Buy
6,077
+907
+18% +$503K ﹤0.01% 2423
2017
Q1
$3.42M Buy
5,170
+245
+5% +$162K ﹤0.01% 2343
2016
Q4
$1.65M Buy
4,925
+1,166
+31% +$390K ﹤0.01% 2737
2016
Q3
$1.13M Buy
3,759
+448
+14% +$135K ﹤0.01% 2875
2016
Q2
$573K Buy
3,311
+87
+3% +$15.1K ﹤0.01% 3168
2016
Q1
$721 Buy
3,224
+59
+2% +$13 ﹤0.01% 3049
2015
Q4
$1.92M Buy
3,165
+46
+1% +$27.9K ﹤0.01% 2512
2015
Q3
$1.6M Buy
3,119
+1,396
+81% +$718K ﹤0.01% 2580
2015
Q2
$753K Buy
1,723
+247
+17% +$108K ﹤0.01% 3035
2015
Q1
$533K Buy
1,476
+161
+12% +$58.1K ﹤0.01% 3170
2014
Q4
$471K Buy
1,315
+74
+6% +$26.5K ﹤0.01% 3219
2014
Q3
$374K Buy
1,241
+392
+46% +$118K ﹤0.01% 3291
2014
Q2
$520K Buy
849
+11
+1% +$6.74K ﹤0.01% 3150
2014
Q1
$561K Buy
+838
New +$561K ﹤0.01% 3102